ERNA vs WAT · P/E 0.0, rev $582.0K vs P/E 32, rev $1.65B
Eterna Therapeutics Inc (ERNA) versus Waters Corporation (WAT) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Waters Corporation (WAT) is a diagnostics & research company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported WAT revenue for 2026-07-04 was $1.65B. Net income was -$136.0M. Revenue was up 29.8% from 2026-04-04 to 2026-07-04. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
Not investment advice. Open the ERNA and WAT stock pages for the full models.
Not investment advice.